CSCI

COSCIENS Biopharma Inc. Common Stock
CSCI

Overview Fund Activity
Delisted

CSCI was delisted on the 3rd of September, 2025.

Back to rankings

31 hedge funds and large institutions have $1.46M invested in COSCIENS Biopharma Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
-3
Holders Change %
-8.82%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
8
Reduced
11
Closed
4
Calls
$473K
Puts
$498K
Net Calls
-$25K
Net Calls Change
-$719K

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
$256K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
$309K
3
N
Natixis
France
$220K
4
Geode Capital Management
Geode Capital Management
Massachusetts
$68K
5
Squarepoint
Squarepoint
New York
$8K

Top Sellers

1
SM
Sabby Management
Florida
$0
2
Goldman Sachs
Goldman Sachs
New York
$63K
3
VF
Virtu Financial
New York
$73K
4
Group One Trading
Group One Trading
Illinois
$46K
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
$56K
Name Holding Trade Value Shares
Change 		Shares
Change %
TC
26
Truvestments Capital
Florida
$2K – – –
FWM
27
Focused Wealth Management
New York
$1K – – –
Royal Bank of Canada
28
Royal Bank of Canada
Ontario, Canada
$1K +$438 +7 +78%
SM
29
Sabby Management
Florida
– -$214K -2,442 Closed
SPIA
30
Steward Partners Investment Advisory
New York
– -$9K -100 Closed
Citigroup
31
Citigroup
New York
– -$1K -10 Closed
RIM
32
Rockbridge Investment Management
New York
– -$1K -8 Closed
1
2